{
    "clinical_study": {
        "@rank": "38386", 
        "arm_group": [
            {
                "arm_group_label": "Assisted hatching group (AH group)", 
                "arm_group_type": "Experimental", 
                "description": "The subjects are going to participate the treatment of assisted hatching in vitro fertilization by Zona Infrared Laser Optical System (ZILOS-TK IVOS Analyzer,Hamilton Thorne Biosciences,USA)."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "The subjects are going to undergo the same procedure except for the treatment of assisted hatching."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether laser-assisted zona thinning improve the\n      implantation rate of the women of advanced age in the first IVF/ICSI cycles"
        }, 
        "brief_title": "The Effect of Laser-assisted Zona Thinning on the Implantation Rate in the Women of Advanced Age", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Female Urogenital Diseases", 
        "condition_browse": {
            "mesh_term": "Urologic Diseases"
        }, 
        "detailed_description": {
            "textblock": "Registry procedures\uff1a\n\n        1. It's required to sign an informed consent form prior to the recruitment of all\n           patients.\n\n        2. Data collection and entry need double check and supervision.\n\n      The outcome measures:\n\n      the implantation rate per embryo transfer miscarriage live birth"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 35y \u2264age\u226446y\n\n          -  Basal FSH value: FSH\u226410IU/L\n\n          -  Day-3 embryos transferred in the fresh IVF/ICSI cycles\n\n          -  the number of embryos available to be transferred on Day-3: \u2265one embryo\n\n        Exclusion Criteria:\n\n          -  cycles with thawed/warmed embryos biopsied for PGD/PGS.\n\n          -  cycles with oocyte donation transfer.\n\n          -  the maximum number of previous unsuccessful IVF attempts: \u2265 3 cycles(transfer cycles)\n\n          -  any cycles with the risk of OHSS, fluid in the uterine cavity, abnormal endometrium,\n             uterine abnormalities,pelvic inflammation, and other acute maternal problems.\n\n          -  One or both spouses have an abnormal karyotype (including polymorphism)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "46 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01765322", 
            "org_study_id": "MCHC-2013-01"
        }, 
        "intervention": {
            "arm_group_label": "Assisted hatching group (AH group)", 
            "description": "The subjects are going to participate the treatment of assisted hatching in vitro fertilization by Zona Infrared Laser Optical System (ZILOS-TK,Hamilton Thorne Biosciences,USA)", 
            "intervention_name": "ZILOS-TK IVOS Analyzer", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 25, 2013", 
        "location": {
            "contact": {
                "email": "swihao@yahoo.com", 
                "last_name": "Wenhao Shi, Master", 
                "phone": "+86-029-87219120"
            }, 
            "facility": {
                "address": {
                    "city": "Xi'an", 
                    "country": "China", 
                    "state": "Shaanxi", 
                    "zip": "710003"
                }, 
                "name": "Maternal and Children Health Care Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Center of Assisted Reproductive Technology", 
        "overall_contact": {
            "email": "shijuanzi123@126.com", 
            "last_name": "Juanzi Shi, Doctor", 
            "phone": "+86-029-87219120"
        }, 
        "overall_official": {
            "affiliation": "Maternal and Children Health Care Hospital", 
            "last_name": "Wenhao Shi, Master", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "China: State Administration of Traditional Chinese Medicine of the People's Republic of China", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the implantation rate per embryo in first fresh embryos transfer cycles", 
            "measure": "The implantation rate", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01765322"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanxi Provincial Maternity and Children's Hospital", 
            "investigator_full_name": "Shi Wenhao", 
            "investigator_title": "Assisted Reproductive Technology Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "The miscarriage", 
            "safety_issue": "Yes", 
            "time_frame": "24 weeks"
        }, 
        "source": "Shanxi Provincial Maternity and Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanxi Provincial Maternity and Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}